Atgenomix is a data and machine learning company that provides an open standard and unified platform for operationalizing biomedical data, analytics, and ML to deliver on the promise of precision medicine. Atgenomix envisions the cloud technology that will transform healthcare in routine clinical genomics and artificial intelligence; and aims to provide the industry with modern computational and analytics technologies that they need to scale data and machine learning in the labs of the future.
Atgenomix BioMed-ICT platform empowers its customers to build their own fully managed precision medicine production from sample to report with an integrated solution stack of cloud services, software technologies, and industry standards. Atgenomix helps Next Generation Sequencing testing providers scale clinical diagnostics portfolio globally; clinical researchers accelerate large-scale omics data processing; and bioinformatics developers release new analysis software products at record-breaking speed.
Atgenomix is a Microsoft partner in gold data and cloud platform competencies, a Nvidia solution partner in accelerating omics data analysis, a Google Health trusted partner in genomics research, a Health Level Seven International (HL7) Gold member, a Global Alliance for Genomics and Health organizational member, and a Taipei Medical University BIOMED Accelerator alumnus.